OpenVSafe by OpenVAERS
Search V-safe

D7J-21524-78645

2 vaccinations 1 coded response 18 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
981 / WA
Registered
2021-04-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-19
    Registered in v-safe
  2. 2021-04-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-19
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-04-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-26
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-05-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-10
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-05-13
    Dose 2 — Pfizer-BioNTech
  14. 2021-05-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-05-20
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-06-14
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-06-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-06-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-08-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-11-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2022-05-15
    Survey response — 12 months, dose 2
    MedDRA: Delivery, Foetal growth restriction, HELLP syndrome, Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Severe Preeclampsia (HELLP syndrome) during pregnancy resulting in a baby with IUGR delivered at 36 weeks.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-05-15
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Hospitalization · 1 call case(s)
  23. 2022-05-17
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-04-19Pfizer-BioNTech
22021-05-13Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — 12 months, dose 2

2022-05-15

Symptoms: Severe Preeclampsia (HELLP syndrome) during pregnancy resulting in a baby with IUGR delivered at 36 weeks.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDelivery · · ✓
SDFoetal growth restriction · · ✓
SDHELLP syndrome · · ✓
SDPre-eclampsia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…